Increasing ciprofloxacin resistance among prevalent urinary tract bacterial isolates in the Gaza Strip

Singapore Medical Journal

Volumn 46, Issue 9, 2005, Pages 457-460

  Astal, Zakaria El ^a  

^a Khan Younis Gaza Strip Palestinian Authority   (Palestine)

Author keywords

Antibiotic resistance; Ciprofloxacin; Urinary tract infection

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN;

ACTINOBACTERIA; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; MONITORING; NONHUMAN; PALESTINE; PREVALENCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS SAPROPHYTICUS; URINALYSIS; URINARY TRACT INFECTION;

ACINETOBACTER; ADOLESCENT; ADULT; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MIDDLE EAST; PILOT PROJECTS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS HAEMOLYTICUS; URINARY TRACT INFECTIONS;

EID: 24344457744     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Gonzalez CM, Schaeffer AJ. Treatment of urinary tract infection: what's old, what's new and what works. World J Urol 1999; 17:372-82.
2. Gupta K. Addressing antibiotic resistance. Dis Mon 2003; 49:99-110.
3. O'Donnell JA, Gelone SP. Fluoroquinolones. Infect Dis Clin North Am 2000; 14:489-513, xi.
4. Schaeffer AJ. The expanding role of fluoroquinolones. Am J Med 2002; 113 Suppl 1A:45S-54S.
5. Kamberi M, Tsutsumi K, Kotegawa T, et al. Influences of urinary pH on ciprofloxacin pharmacokinetics in humans and antimicrobial activity in vitro versus those of sparfloxacin. Antimicrob Agents Chemother 1999; 43:525-9.
6. King DE, Malone R, Lilley SH. New classification and update on the quinolone antibiotics. Am Fam Physician 2000; 61:2741-8.
7. Shao HF, Wang WP, Zhang XW, et al. [Distribution and resistance trends of pathogens from urinary tract infections and impact on management.] Zhonghua Nan Ke Xue 2003; 9(9):690-2, 696. Chinese.
8. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 2003; 51:69-76.
9. Iqbal J, Rahman M, Kabir MS, et al. Increasing ciprofloxacin resistance among prevalent urinary tract bacterial isolates in Bangladesh. Jpn J Med Sci Biol 1997; 50:241-50.
10. Astal Z, El-Manama A, Sharif FA. Antibiotic resistance of bacteria associated with community-acquired urinary tract infections in the southern area of the Gaza Strip. J Chemother 2002; 14:259-64.
11. Astal Z, Sharif FA, Abdallah SA, et al. Multiresistant Escherichia coli isolated from women with community-acquired urinary tract infections in Gaza Strip. J Chemother 2002; 14:637-8.
12. Miller K, O'Neill AJ, Chopra I. Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes. J Antimicrob Chemother 2002; 49:925-34.
13. Burnett RW, Haber MH, Hackel E, et al. Clinical laboratory medicine. Philadelphia: Williams & Wilkins, 1994:1113-20.
14. Vandepitte J, El-Nageh MM, Tikhomirov E, et al. Guidelines for antimicrobial resistance surveillance. In: WHO Regional Publications, World Health Organization, Regional Office for the Eastern Mediterranean, Alexandria, Egypt, 1996; 15:13-22.
15. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized simple disk method. Am J Clin Pathol 1966; 45:493-6.
16. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Eleventh informational supplement. Approved standard M100-S11. Wayne, PA: National Committee for Clinical Laboratory Standards, 2001; 21.
17. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon 2003; 49:71-82.
18. Navaneeth BV, Belwadi S, Suganthi N. Urinary pathogens' resistance to common antibiotics: a retrospective analysis. Trop Doct 2002; 32:20-2.
19. Mathai D, Jones RN, Pfaller MA. Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America). Diagn Microbiol Infect Dis 2001; 40:129-36.
20. Farooqi BJ, Shareeq F, Rizvi QK, et al. Changing pattern of antimicrobial susceptibility of organisms causing community acquired urinary tract infections. J Pak Med Assoc 2000; 50:369-73.
21. Sahm DF, Thornsberry C, Mayfield DC, et al. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob Agents Chemother 2001; 45:1402-6.
22. Perfetto EM, Keating K, Merchant S, et al. Acute uncomplicated UTI and E. coli resistance: implications for first-line empirical antibiotic therapy. J Manag Care Pharm 2004; 10:17-25.
23. Diekema DJ, BootsMiller BJ, Vaughn TE, et al. Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clin Infect Dis 2004; 38:78-85.
24. Tolun V, Kucukbasmaci O, Torumkuney-Akbulut D, et al. Relationship between ciprofloxacin resistance and extended-spectrum beta-lactamase production in Escherichia coli and Klebsiella pneumoniae strains. Clin Microbiol Infect 2004; 10:72-5.